Jiangsu CoWin Biotech Co., Ltd. (SHA:688426)
China · Delayed Price · Currency is CNY 23.15
+0.52 (2.30%)
At close: Mar 6, 2026
Jiangsu CoWin Biotech Market Cap
Jiangsu CoWin Biotech has a market cap or net worth of 2.54 billion as of March 6, 2026. Its market cap has decreased by -3.55% in one year.
Market Cap
2.54B
Enterprise Value
1.97B
Revenue
193.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
23.15
Market Cap Chart
Since October 25, 2022, Jiangsu CoWin Biotech's market cap has decreased from 4.06B to 2.54B, a decrease of -37.37%. That is a compound annual growth rate of -12.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 2.54B | -2.85% |
| Dec 31, 2025 | 2.62B | -17.62% |
| Dec 31, 2024 | 3.18B | -7.26% |
| Dec 29, 2023 | 3.43B | 3.44% |
| Dec 30, 2022 | 3.31B | -18.44% |
| Oct 25, 2022 | 4.06B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Sihuan Bioengineering | 2.89B |
| Landfar Bio-medicine | 2.87B |
| Novoprotein Scientific | 2.83B |
| Shanghai Universal Biotech | 2.68B |
| Jilin Jian Yisheng Pharmaceutical | 2.64B |
| Shandong Sito Bio-technology | 2.61B |
| Shanghai Serum Bio-Technology | 2.53B |
| Zhejiang East Asia Pharmaceutical | 2.41B |